The market cap of 1127.74 for Loxo Oncology, Inc. in today’s market indicated its current strength, making the company’s shares a lucrative one. The company’s existing price is 44.75 with a change in volume of 209941. Loxo Oncology, Inc.’s target price was set to 50 with an IPO date at 8/1/2014. The Return on Equity currently counts at -48.30%.
*Real time graph of Loxo Oncology, Inc. (NASDAQ: LOXO)
Loxo Oncology, Inc. (NASDAQ:LOXO) exhibits a P/E ratio of *tba with a forward P/E of *tba. At present, the PEG is valued at *tba alongside the P/S ratio of *tba and P/B ratio of 6.98. The corporation showed significant change in the EPS section with its current EPS of -3.45. The EPS growth in the running year displays a value of -63.10%. Loxo Oncology, Inc. NASDAQ has an Earning Per Share for the upcoming year at -63.10%. The EPS growth for the past five (5) years shows a value of *tba, whilst the EPS value for the next five (5) years shows a figure of *tba. Company has a sales growth for the last five (5) years is valued at *tba.
Indicating how profitable Loxo Oncology, Inc. (NASDAQ:LOXO) is relative to its assets, the ROA value is displayed at -46.00%. The ROA for Loxo Oncology, Inc. tells us exactly what earnings were generated from the invested capital. An ROI of *tba for Loxo Oncology, Inc. evaluates and compares the efficiency of the various numbers of investments relative to the cost of investments.
The current ratio for Loxo Oncology, Inc. (NASDAQ:LOXO) shows a rate of 9.4 with its quick ratio of 9.4. The long term debt/equity is currently valued at 0 with a total debt/equity of 0. The gross margin parades a value of *tba with the company running a operating margin of *tba and a profit margin of *tba.
The 20-day Simple Moving average for Loxo Oncology, Inc. NASDAQ is measured to be 2.67% in conjunction with the 200-Day Simple Moving Average of 46.65%. Company has a 52-Week High of -5.71% and a 52-Week Low of 161.09%. Loxo Oncology, Inc. experienced its Day High at -5.71%, with its Day Low of 21.77%.
The performance week demonstrated a value of -7.72%. The monthly performance exhibited a rate of -7.60% with an annual performance rate of 50.37%. The performance for the year to date shows a rate of 31.03%. The corporation has a weekly volatility of 5.25% resulting a monthly volatility of 5.30%.
Loxo Oncology, Inc. value Change from Open was at 1.04% with a Gap of 5.25%.
Disclaimer: Drafted figures and information laid out in the above reporting are only a work of the authors. They do not reflect on the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Examples charted in this article above are only cases with information collected from numerous sources. The authority will not be accountable for anyone who makes stock portfolio or financial decisions as per this reporting, which has been constructed only on limited and open source information. Conclusions from the analysis of the editorial shall not portray the position of any analysts or financial professionals.